Cover Image
市場調查報告書

次世代定序 (NGS) 的全球市場:2015年∼2019年

Global Next Generation Sequencing Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 285559
出版日期 內容資訊 英文 72 Pages
訂單完成後即時交付
價格
Back to Top
次世代定序 (NGS) 的全球市場:2015年∼2019年 Global Next Generation Sequencing Market 2015-2019
出版日期: 2015年05月06日 內容資訊: 英文 72 Pages
簡介

全球次世代定序 (NGS) 市場預測從2014年∼2019年將以年複合成長率(CAGR)21.36%的速度成長。

本報告提供全球次世代定序 (NGS) 市場相關調查分析,提供您市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 基因定序成本分析

第8章 設備費

第9章 給付與適用範圍

第10章 對NGS檢驗的法規的觀點

  • NGS檢驗的分析性能
  • 觀看NGS檢驗臨床成績

第11章 市場區隔:各產品

  • 全球NGS市場:各產品
  • 全球NGS市場:試劑·消耗品別
    • 市場規模與預測
  • 全球NGS市場:各設備
    • 市場規模與預測

第12章 市場區隔:各終端用戶

  • 全球NGS市場:各終端用戶

第13章 市場區隔:各技術

  • 全球NGS市場:各技術

第14章 地區區分

  • 全球NGS市場:各區域區隔
  • 南北美洲的NGS市場
    • 市場規模與預測
  • 歐洲·中東·非洲的NGS市場
    • 市場規模與預測
  • 亞太地區的NGS市場
    • 市場規模與預測

第15章 購買標準

第16章 推動市場成長要素

第17章 成長推動因素與其影響

第18章 市場課題

第19章 成長推動因素與課題的影響

第20章 市場趨勢

第21章 趨勢與其影響

第22章 業者情勢

  • 競爭模式
  • 市場佔有率分析
  • 其他卓越供應商

第23章 主要供應商分析

  • Illumina
  • Roche Diagnostics
  • Life Technologies

第24章 相關報告

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR5886

About NGS

Next generation sequencing (NGS) technology is used to sequence millions of small fragments of DNA simultaneously. The technology is similar to capillary electrophoresis where the bases of small fragments of DNA are sequentially identified from signals emitted, and each fragment is resynthesized from a DNA template strand. The major difference is that NGS process is extended across millions of reactions in a massively parallel fashion, rather than restricted to a single or a few DNA fragments. This technology enables rapid sequencing of large stretches of DNA base pairs spanning entire genomes with highly sophisticated instruments capable of producing hundreds of gigabytes of data in a single sequencing run. NGS finds application in whole genome, exome, and transcriptome sequencing that provide a high-resolution and global view of various applications such as the cancer genome. NGS coupled with bioinformatics tools has revolutionized cancer research, diagnosis, and therapy. This technology helps to track and trace the spread of disease and foreign contaminants in drugs.

Technavio's analysts forecast the global next generation sequencing market to grow at a CAGR of 21.36% over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the global next generation sequencing market for the period 2015-2019. The global next generation sequencing market is divided into two segments: equipment, and reagents and consumables. To calculate the market size, the report considers the revenue generated from the sales of equipment, and reagents and consumables used in next generation sequencing in the following customer segments:

  • Commercial entities such as hospitals and pharmaceutical and life sciences companies
  • Research institutes

Technavio's report, Global Next Generation Sequencing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Illumina
  • Roche Diagnostics
  • Thermo Fischer Scientific

Other Prominent Vendors

  • 10X Genomics
  • 23andMe
  • Ambry Genetics
  • Axeq Technologies
  • Beijing Genomics Institute
  • CLC bio
  • Clontech Laboratories
  • Fluidigm
  • Foundation Medicine
  • GATC Biotech
  • GeneDx
  • GENEWIZ
  • Gnomegen
  • Good Start Genetics
  • Ingenuity Systems
  • Knome
  • NABsys
  • Oxford Nanopore Technologies
  • Pathogenica
  • PerkinElmer
  • RainDance Technologies
  • Rubicon Genomics
  • Sequenom
  • Sigma-Aldrich
  • Source Biosciences
  • Takara Bio

Market Driver

  • Increased Adoption by New Customers
  • For a full, detailed list, view our report

Market Challenge

  • Technical and Implementation Issues
  • For a full, detailed list, view our report

Market Trend

  • Strategic Alliances
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Genome Sequencing Cost Analysis

08. Cost of Equipment

09. Reimbursement and Coverage

10. Regulatory Point of View for NGS Tests

  • 10.1. Analytical Performance of NGS Tests
  • 10.2. Accessing Clinical Performance of NGS Tests
    • 10.2.1. Leveraging Genetic Databases to Evaluate Clinical Performance
    • 10.2.2. Communicate Information about Less Well-known Variants

11. Market Segmentation by Product

  • 11.1. Global NGS Market by Product 2014-2019
  • 11.2. Global NGS Market by Reagents and Consumables
    • 11.2.1. Market Size and Forecast
  • 11.3. Global NGS Market by Equipment
    • 11.3.1. Market Size and Forecast

12. Market Segmentation by End-user

  • 12.1. Global NGS Market by End-user 2014-2019

13. Market Segmentation by Technology

  • 13.1. Global NGS Market by Technology
    • 13.1.1. Sequencing by Synthesis
    • 13.1.2. Ion Semiconductor Sequencing
    • 13.1.3. Sequencing by Ligation
    • 13.1.4. Pyrosequencing
    • 13.1.5. SMRT Sequencing

14. Geographical Segmentation

  • 14.1. Global NGS Market by Geographical Segmentation 2014-2019
  • 14.2. NGS Market in Americas
    • 14.2.1. Market Size and Forecast
  • 14.3. NGS Market in EMEA
    • 14.3.1. Market Size and Forecast
  • 14.4. NGS Market in APAC
    • 14.4.1. Market Size and Forecast

15. Buying Criteria

16. Market Growth Drivers

17. Drivers and their Impact

18. Market Challenges

19. Impact of Drivers and Challenges

20. Market Trends

21. Trends and their Impact

22. Vendor Landscape

  • 22.1. Competitive Scenario
    • 22.1.1. Key News
    • 22.1.2. Mergers and Acquisitions
  • 22.2. Market Share Analysis 2014
  • 22.3. Other Prominent Vendors

23. Key Vendor Analysis

  • 23.1. Illumina
    • 23.1.1. Key Facts
    • 23.1.2. Business Overview
    • 23.1.3. Business Segmentation
    • 23.1.4. Geographical Segmentation by Revenue 2013
    • 23.1.5. Business Strategy
    • 23.1.6. Key Information
    • 23.1.7. SWOT Analysis
  • 23.2. Roche Diagnostics
    • 23.2.1. Key Facts
    • 23.2.2. Business Overview
    • 23.2.3. Business Segmentation by Revenue 2013
    • 23.2.4. Geographical Segmentation by Revenue 2013
    • 23.2.5. Business Strategy
    • 23.2.6. Key Developments
    • 23.2.7. SWOT Analysis
  • 23.3. Life Technologies now part of Thermo Fisher Scientific
    • 23.3.1. Key Facts
    • 23.3.2. Business Overview
    • 23.3.3. Business Segmentation by Revenue 2012
    • 23.3.4. Geographical Segmentation by Revenue 2012
    • 23.3.5. Business Strategy
    • 23.3.6. Recent Developments
    • 23.3.7. SWOT Analysis

24. Other Reports in this Series

List Of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global NGS Market 2014-2019 ($ million)
  • Exhibit 3: Cost per Genome 2001-2014 ($ million)
  • Exhibit 4: Cost per Megabase of DNA Sequence 2001-2014 ($)
  • Exhibit 5: Estimated Cost of NGS Equipment
  • Exhibit 6: Global NGS Market by Product 2014
  • Exhibit 7: Global NGS Market by Product 2019
  • Exhibit 8: Global NGS Market by Product 2014-2019
  • Exhibit 9: Global NGS Market by Reagents and Consumables 2014-2019 ($ million)
  • Exhibit 10: Global NGS Market by Equipment 2014-2019 ($ million)
  • Exhibit 11: Global NGS Market by End-user 2014
  • Exhibit 12: Global NGS Market by Geographical Segmentation 2014
  • Exhibit 13: Global NGS Market by Geographical Segmentation 2019
  • Exhibit 14: Global NGS Market by Geographical Segmentation 2014-2019
  • Exhibit 15: NGS Market in Americas 2014-2019 ($ million)
  • Exhibit 16: NGS Market in EMEA 2014-2019 ($ million)
  • Exhibit 17: NGS Market in APAC 2014-2019 ($ million)
  • Exhibit 18: Market Share Analysis 2014
  • Exhibit 19: Illumina: Business Segmentation
  • Exhibit 20: Illumina: Geographical Segmentation by Revenue 2013
  • Exhibit 21: Roche Diagnostics: Business Segmentation by Revenue 2013
  • Exhibit 22: Roche Diagnostics: Geographical Segmentation by Revenue 2013
  • Exhibit 23: Life Technologies: Business Segmentation by Revenue 2012
  • Exhibit 24: Life Technologies: Geographical Segmentation by Revenue 2012
Back to Top